These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11502741)
1. An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer. Reiter R; Wellstein A; Riegel AT J Biol Chem; 2001 Oct; 276(43):39736-41. PubMed ID: 11502741 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471 [TBL] [Abstract][Full Text] [Related]
3. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity. Reiter R; Oh AS; Wellstein A; Riegel AT Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461 [TBL] [Abstract][Full Text] [Related]
4. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content. Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825 [TBL] [Abstract][Full Text] [Related]
5. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752 [TBL] [Abstract][Full Text] [Related]
6. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. List HJ; Lauritsen KJ; Reiter R; Powers C; Wellstein A; Riegel AT J Biol Chem; 2001 Jun; 276(26):23763-8. PubMed ID: 11328819 [TBL] [Abstract][Full Text] [Related]
7. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902 [TBL] [Abstract][Full Text] [Related]
8. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation. Erenburg I; Schachter B; Mira y Lopez R; Ossowski L Mol Endocrinol; 1997 Dec; 11(13):2004-15. PubMed ID: 9415404 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194 [TBL] [Abstract][Full Text] [Related]
10. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells. Azorsa DO; Cunliffe HE; Meltzer PS Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608 [TBL] [Abstract][Full Text] [Related]
11. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator. Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419 [TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637 [TBL] [Abstract][Full Text] [Related]
14. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma. Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Bouras T; Southey MC; Venter DJ Cancer Res; 2001 Feb; 61(3):903-7. PubMed ID: 11221879 [TBL] [Abstract][Full Text] [Related]
16. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells. De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907 [TBL] [Abstract][Full Text] [Related]
17. AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines. Wong LJ; Dai P; Lu JF; Lou MA; Clarke R; Nazarov V BMC Cancer; 2006 May; 6():111. PubMed ID: 16670003 [TBL] [Abstract][Full Text] [Related]
18. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796 [TBL] [Abstract][Full Text] [Related]
19. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients. Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282 [TBL] [Abstract][Full Text] [Related]
20. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland. Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]